SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-22-074786
Filing Date
2022-06-27
Accepted
2022-06-27 16:37:09
Documents
3
Group Members
NOVARTIS AG

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2219332d1_sc13g.htm SC 13G 69392
2 EXHIBIT 1 tm2219332d1_ex99-1.htm EX-99.1 37001
3 EXHIBIT 2 tm2219332d1_ex99-2.htm EX-99.2 6342
  Complete submission text file 0001104659-22-074786.txt   114261
Mailing Address LICHTSTRASSE 35 CH-4002 BASEL V8
Business Address LICHTSTRASSE 35 CH-4002 BASEL V8 212-830-2474
NOVARTIS PHARMA AG (Filed by) CIK: 0001030617 (see all company filings)

Type: SC 13G

Mailing Address 302 EAST PETTIGREW STREET SUITE A-100 DURHAM NC 27701
Business Address 302 EAST PETTIGREW STREET SUITE A-100 DURHAM NC 27701 919-314-5512
PRECISION BIOSCIENCES INC (Subject) CIK: 0001357874 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90975 | Film No.: 221045100
SIC: 2836 Biological Products, (No Diagnostic Substances)